147 related articles for article (PubMed ID: 9307865)
1. The U1 snRNP complex: an autoantigen in connective tissue diseases. An update.
Klein Gunnewiek JM; van de Putte LB; van Venrooij WJ
Clin Exp Rheumatol; 1997; 15(5):549-60. PubMed ID: 9307865
[TBL] [Abstract][Full Text] [Related]
2. Apoptotic modifications affect the autoreactivity of the U1 snRNP autoantigen.
Hof D; Raats JM; Pruijn GJ
Autoimmun Rev; 2005 Jul; 4(6):380-8. PubMed ID: 16081029
[TBL] [Abstract][Full Text] [Related]
3. Epitope mapping of the U1 small nuclear ribonucleoprotein particle in patients with systemic lupus erythematosus and mixed connective tissue disease.
Somarelli JA; Mesa A; Rodriguez R; Avellan R; Martinez L; Zang YJ; Greidinger EL; Herrera RJ
Lupus; 2011 Mar; 20(3):274-89. PubMed ID: 21362751
[TBL] [Abstract][Full Text] [Related]
4. Clinical associations with autoantibody reactivities to individual components of U1 small nuclear ribonucleoprotein.
Kaneko Y; Suwa A; Hirakata M; Ikeda Y; Kuwana M
Lupus; 2010 Mar; 19(3):307-12. PubMed ID: 20015915
[TBL] [Abstract][Full Text] [Related]
5. The U1-snRNP complex: structural properties relating to autoimmune pathogenesis in rheumatic diseases.
Kattah NH; Kattah MG; Utz PJ
Immunol Rev; 2010 Jan; 233(1):126-45. PubMed ID: 20192997
[TBL] [Abstract][Full Text] [Related]
6. Analysis of T cell receptors specific for U1-70kD small nuclear ribonucleoprotein autoantigen: the alpha chain complementarity determining region three is highly conserved among connective tissue disease patients.
Talken BL; Lee DR; Caldwell CW; Quinn TP; Schäfermeyer KR; Hoffman RW
Hum Immunol; 1999 Mar; 60(3):200-8. PubMed ID: 10321956
[TBL] [Abstract][Full Text] [Related]
7. The fate of the U1 snRNP autoantigen during apoptosis: implications for systemic autoimmunity.
Malmegrim KC; Pruijn GJ; van Venrooij WJ
Isr Med Assoc J; 2002 Sep; 4(9):706-12. PubMed ID: 12440236
[TBL] [Abstract][Full Text] [Related]
8. The U2 small nuclear ribonucleoprotein particle as an autoantigen. Analysis with sera from patients with overlap syndromes.
Craft J; Mimori T; Olsen TL; Hardin JA
J Clin Invest; 1988 Jun; 81(6):1716-24. PubMed ID: 2968364
[TBL] [Abstract][Full Text] [Related]
9. Differential immunoglobulin class-mediated responses to components of the U1 small nuclear ribonucleoprotein particle in systemic lupus erythematosus and mixed connective tissue disease.
Mesa A; Somarelli JA; Wu W; Martinez L; Blom MB; Greidinger EL; Herrera RJ
Lupus; 2013 Nov; 22(13):1371-81. PubMed ID: 24158973
[TBL] [Abstract][Full Text] [Related]
10. A murine model of mixed connective tissue disease induced with U1 small nuclear RNP autoantigen.
Greidinger EL; Zang Y; Jaimes K; Hogenmiller S; Nassiri M; Bejarano P; Barber GN; Hoffman RW
Arthritis Rheum; 2006 Feb; 54(2):661-9. PubMed ID: 16453294
[TBL] [Abstract][Full Text] [Related]
11. Detection and epitope analysis of autoantigen-reactive T cells to the U1-small nuclear ribonucleoprotein A protein in autoimmune disease patients.
Okubo M; Yamamoto K; Kato T; Matsuura N; Nishimaki T; Kasukawa R; Ito K; Mizushima Y; Nishioka K
J Immunol; 1993 Jul; 151(2):1108-15. PubMed ID: 7687615
[TBL] [Abstract][Full Text] [Related]
12. Characterization of recombinant human autoantibody fragments directed toward the autoantigenic U1-70K protein.
Degen WG; Pieffers M; Welin-Henriksson E; van den Hoogen FH; van Venrooij WJ; Raats JM
Eur J Immunol; 2000 Oct; 30(10):3029-38. PubMed ID: 11069087
[TBL] [Abstract][Full Text] [Related]
13. Association of phosphorylated serine/arginine (SR) splicing factors with the U1-small ribonucleoprotein (snRNP) autoantigen complex accompanies apoptotic cell death.
Utz PJ; Hottelet M; van Venrooij WJ; Anderson P
J Exp Med; 1998 Feb; 187(4):547-60. PubMed ID: 9463405
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies that stabilize U1snRNP are a significant component of human autoantibodies to snRNP and delay proteolysis of sm antigens in vitro.
Satoh M; Akaogi J; Kuroda Y; Nacionales DC; Yoshida H; Yamasaki Y; Reeves WH
J Rheumatol; 2004 Dec; 31(12):2382-9. PubMed ID: 15570638
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory myositis associated with anti-U1-small nuclear ribonucleoprotein antibodies: a subset of myositis associated with a favourable outcome.
Coppo P; Clauvel JP; Bengoufa D; Oksenhendler E; Lacroix C; Lassoued K
Rheumatology (Oxford); 2002 Sep; 41(9):1040-6. PubMed ID: 12209039
[TBL] [Abstract][Full Text] [Related]
16. Autoantibody production against the U small nuclear ribonucleoprotein particle proteins E, F and G in patients with connective tissue diseases.
Reuter R; Rothe S; Habets W; Van Venrooij WJ; Lührmann R
Eur J Immunol; 1990 Feb; 20(2):437-40. PubMed ID: 2138085
[TBL] [Abstract][Full Text] [Related]
17. Anti-RNP immunity: implications for tissue injury and the pathogenesis of connective tissue disease.
Keith MP; Moratz C; Tsokos GC
Autoimmun Rev; 2007 Mar; 6(4):232-6. PubMed ID: 17317614
[TBL] [Abstract][Full Text] [Related]
18. Human autoimmune sera as molecular probes for the identification of an autoantigen kinase signaling pathway.
Kamachi M; Le TM; Kim SJ; Geiger ME; Anderson P; Utz PJ
J Exp Med; 2002 Nov; 196(9):1213-25. PubMed ID: 12417631
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune response to U1 small nuclear ribonucleoprotein (U1 snRNP) associated with cytomegalovirus infection.
Newkirk MM; van Venrooij WJ; Marshall GS
Arthritis Res; 2001; 3(4):253-8. PubMed ID: 11438044
[TBL] [Abstract][Full Text] [Related]
20. T cell immunity in connective tissue disease patients targets the RNA binding domain of the U1-70kDa small nuclear ribonucleoprotein.
Greidinger EL; Foecking MF; Schäfermeyer KR; Bailey CW; Primm SL; Lee DR; Hoffman RW
J Immunol; 2002 Sep; 169(6):3429-37. PubMed ID: 12218166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
